Avalo Therapeutics, Inc.

SEC 4 · Filed

0002017156-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Mar 28, 2026

Exercise or conversion by Truex Samantha

Security
Restricted Stock Units
Code
M
Shares
3,166
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-03-28",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Restricted stock units convert into common stock on a one-for-one basis.",
    "F2": "On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person\u0027s continued service on such vesting date."
  },
  "owners": [
    {
      "cik": "0002017156",
      "name": "Truex Samantha",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "3167",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Restricted Stock Units",
  "shares": "3166",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "3166"
}
Insider transactionsEvent date Mar 28, 2026

Exercise or conversion by Truex Samantha

Security
Common Stock
Code
M
Shares
3,166
Price per share
Unreported
Structured facts
{
  "code": "M",
  "date": "2026-03-28",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Restricted stock units convert into common stock on a one-for-one basis."
  },
  "owners": [
    {
      "cik": "0002017156",
      "name": "Truex Samantha",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "6333",
  "price": null,
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Stock",
  "shares": "3166",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}